SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Evotec and Bristol Myers Squibb Advance Partnership After Second IND Acceptance

The FDA accepted a second investigational new drug application under the companies’ strategic protein degradation partnership.

EVO

Related stories